<DOC>
	<DOCNO>NCT02441387</DOCNO>
	<brief_summary>Predictors response pharmacological treatment major depressive disorder investigate . One hundred twenty patient include naturalistic clinical trial . Psychopathology , personality trait , cognitive performance , brain structural change genetic polymorphism evaluate . Patients follow 18 month pharmacological treatment algorithm evaluate monthly 6th month every 3 month , 18 month . Psychoeducation offer patient remit 3 month pharmacological tretment .</brief_summary>
	<brief_title>Predictors Outcome Late Life Depression</brief_title>
	<detailed_description>The relevance depression prevention treatment old people tend raise future year , consider rapid increase elderly population Brazil grow impact depression ( third cause global burden diseases world accord World Health Association 2004 report ) . The association structural brain change treatment response patient late-life depression ( LLD ) remain intriguing area research . Predictors response pharmacological treatment major depressive disorder investigate 120 elderly patient , include naturalistic clinical trial , evaluate psychopathology , personality trait , cognitive performance , brain structural change genetic polymorphism . Patients follow 18 month treatment algorithm depression evaluate monthly 6th month every 3 month , 18 month , assess factor associate response treatment . Patients antidepressant treatment group reach remission ( MADRS score &lt; =8 ) 3 month pharmacological treatment invite part psychoeducation program . If patient accepts psychoeducation intervention , randomize psychoeducation ( pharmacological treatment plus psychoeducation ) treatment usual ( pharmacological treatment ) . The psychoeducation program consist 10 individual weekly session , conduct trained psychologist explain main concept depression symptom , importance adhere treatment , main side effect pharmacological treatment , cope daily difficulty .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>60 year old Major depression ( DSMIVTR ) Evaluated MINI Willing participate . Less 60 year old Dementia syndrome Delirium organic mental disorder Alcohol/drug dependence Anxiety disorder , psychiatric disorder , willing ( able ) participate</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>depression</keyword>
	<keyword>elderly</keyword>
	<keyword>remission</keyword>
	<keyword>treatment response</keyword>
	<keyword>predictor response</keyword>
	<keyword>cognitive decline</keyword>
	<keyword>structural neuroimage</keyword>
	<keyword>genetic polymorphism</keyword>
	<keyword>psychoeducation</keyword>
</DOC>